Heterogeneous nuclear ribonucleoprotein C-like 3 (HNRNPCL3)

Heterogeneous nuclear ribonucleoprotein C-like 3 (HNRNPCL3) is a predicted RNA-binding protein, part of the broader heterogeneous nuclear ribonucleoproteins (hnRNP) family, which are involved in RNA processing, stabilization, transport, and metabolism within the nucleus. The specific molecular and biological functions of HNRNPCL3 are not well characterized, and it is currently considered a predicted gene product with a presumed role in RNA binding and nuclear localization. There is no evidence that HNRNPCL3 is a therapeutically relevant drug target, nor is it documented to play a specific role in disease or as a biomarker. Most functional data and disease associations available pertain to other hnRNP family members, not to HNRNPCL3 itself. There is insufficient detail on HNRNPCL3 in the current biomedical literature; main sources only list its predicted function and localization, without evidence of established physiological or disease roles. The target may be confused with other hnRNP C-like proteins, as the naming is redundant in the literature—be cautious, as HNRNPCL2 and HNRNPCL4 are described as "not classified as part of the HNRNP family" due to cytoplasmic localization and low expression. The HNRNP protein family at large is well studied, but HNRNPCL3 is not established as a receptor, therapeutic target, or clinically relevant biomolecule. No known drugs, mechanisms, biomarkers, or safety concerns are described for this molecule. Based on all available evidence, there is something incorrect or low-confidence about considering HNRNPCL3 as a therapeutically relevant and well-characterized target.

Other names

HNRNPCL3HNRNPCL2HNRNPCL4heterogeneous nuclear ribonucleoprotein C-like 3heterogeneous nuclear ribonucleoprotein C-like 2heterogeneous nuclear ribonucleoprotein C-like 4hnRNP C-like-2